New Drug Target for Acute Myeloid Leukaemia

News   Nov 28, 2017 | Original story from Wellcome Trust Sanger Institute

 
New Drug Target for Acute Myeloid Leukaemia

Acute myeloid leukamia (AML) cells. Genomic research has found that AML cannot survive without the METTL3 gene, making it a strong therapeutic target. Image credit: The Armed Forces Institute of Pathology (AFIP)

 
 
 

RELATED ARTICLES

Adipocyte Development Spurred by Fracking Chemicals and Wastewater

News

New study demonstrates the effect of wastewater contaminants on adipocyte development and lipid accumulation

READ MORE

Chemists Teach Enzyme New Tricks

News

Princeton chemists have found a way to make a naturally occurring enzyme take on a new, artificial role, which has significant implications for modern chemistry, including pharmaceutical production.

READ MORE

Discovery Advances Efforts to Prevent Spread of Cancer

News

Newly identified gene targets could be key to preventing the spread of cancer, new University of Alberta research has shown.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy